Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Observational Survey Assessing the Factors of Treatment Intensification in Uncontrolled Hypertensive Patients Under a Combination Therapy, Either Fixed or Not, of a Renin-Angiotensin System Blocker (RASB) and Hydrochlorothiazide (HCTZ), According to Their Level of Cardiovascular Risk.

This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients

Inclusion Criteria:

• Men or women over 18
• Hypertensive patients
• Uncontrolled hypertension (blood pressure >/=140/90 mmHg on the day of consultation or >/=130/80 mmHg in diabetic patients or in patients suffering from kidney failure, or in elderly patients with a systolic blood pressure >/=150 mmHg (in the absence of orthostatic hypotension)
• Patients treated with a combination, fixed or not, of Renin-Angiotensin System Blocker (RASB) + Hydrochlorothiazide (HCTZ)
• Patients examined in common medical care practice, whatever the reason for consultation
• Patients informed of the study